Treatment and prevention of infective endocarditis

Expert Opinion on Pharmacotherapy

Volumn 3, Issue 2, 2002, Pages 131-145

  Delahaye, François ^a   Hoen, Bruno ^a   McFadden, Eugène ^a   Roth, Olivier ^a   de Gevigney, Guy ^a  

^a LOUIS PRADEL HOSPITAL   (France)

Author keywords

Antibiotics; Infective endocarditis; Prevention; Treatment

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN; AMPHOTERICIN B; ANTIBIOTIC AGENT; BETA LACTAM; CEFAMANDOLE; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLOXACILLIN; DALFOPRISTIN PLUS QUINUPRISTIN; DOXYCYCLINE; FOSFOMYCIN; FUSIDIC ACID; GENTAMICIN; GLYCOPEPTIDE; HYDROXYCHLOROQUINE; METICILLIN; NETILMICIN; OXACILLIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SISOMICIN; SODIUM; STREPTOMYCIN; TEICOPLANIN; UNINDEXED DRUG; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; BACTERIAL ENDOCARDITIS; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; BARTONELLA; BLOOD CULTURE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DENTISTRY; DRUG ADMINISTRATION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CHOICE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG POTENTIATION; EMBOLISM; FUNGUS; GENERAL ANESTHESIA; GRAFT INFECTION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEART SURGERY; HEART VALVE PROSTHESIS; HUMAN; INFECTION RISK; MEDICAL SPECIALIST; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; OUTPATIENT CARE; PATIENT MONITORING; REVIEW; RISK ASSESSMENT; STROKE; UPPER RESPIRATORY TRACT; UROLOGICAL PROCEDURES;

ANTI-BACTERIAL AGENTS; BACTEREMIA; ENDOCARDITIS, BACTERIAL; HUMANS; RISK;

EID: 0036167957     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.3.2.131     Document Type: Review

References (87)

1. Characteristics of infective endocarditis in France in 1991. A 1-year survey
2. Antibiotic treatment of streptococcal, enterococcal and staphylococcal endocarditis
3. Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci and HACEK microorganisms. American Heart Association
4. Staphylococcal endocarditis. Recommendations for therapy
5. Antibiotic treatment of infective endocarditis due to viridans streptococci, enterococci and other streptococci
6. Simulated human serum profiles of one daily dose of ceftriaxone plus netilmicin in treatment of experimental streptococcal endocarditis
7. Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone and netilmicin for 14 days: A prospective multicenter study
8. Ceftriaxone once daily for four weeks compared with ceftriaxone plus gentamicin once daily for two weeks for treatment of endocarditis due to penicillin-susceptible streptococci
9. Treatment of endocarditis with teicoplanin: A retrospective analysis of 104 cases
10. Outpatient treatment of infective endocarditis
11. Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone sodium for 4 weeks. Efficacy and outpatient treatment feasibility
12. Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis
13. Treatment of right-sided Staphylococcus aureus endocarditis in intravenous drug users with ciprofloxacin and rifampicin
14. Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: Two-week combination therapy
15. Prospective evaluation of a two-week course of intravenous antibiotics in intravenous drug addicts with infective endocarditis. Grupo de Estudio de Enfermedades Infecciosas de la Provincia de Cádiz
16. Recommendations pour le diagnostic microbiologique et l'étude anatomopathologique des valves cardiaques au cours de l'endocardite infectieuse
17. Infective endocarditis in patients with negative blood cultures: Analysis of 88 cases from a one-year nationwide survey in France
18. Treatment of Q fever endocarditis: Comparison of 2 regimens containing doxycycline and ofloxacin or hydroxychloroquine
19. Brucella endocarditis: The role of combined medical and surgical treatment
20. Diagnosis of 22 new cases of Bartonella endocarditis
21. Lack of bactericidal effect of antibiotics except aminoglycosides on Bartonella (Rochalimaea) henselae
22. Fungal prosthetic valve endocarditis in 16 patients. An 11-year experience in a tertiary care hospital
23. Candida prosthetic valve endocarditis: Prospective study of six cases and review of the literature
24. Outpatient treatment of infective endocarditis
25. Outpatient intravenous antibiotic therapy for endocarditis
26. Activities of the combination of quinupristin-dalfopristin with rifampin in vitro and in experimental endocarditis due to Staphylococcus aureus resistance to macrolide-lincosamide-streptogramin antibiotics
27. Quinupristin/dalfopristin for treatment of MRSA endocarditis refractory to conventional therapy
28. Staphylococcus epidermidis endocarditis treated with RP 59500 (quinupristin/dalfopristin)
29. Treatment of methicillin-resistant Staphylococcus aureus infectious with quinupristin-dalfopristin in patients intolerant of or failing prior therapy
30. Treatment of vancomycin-resistant Enterococcus faecium with RP 59500 (quinupristin-dalfopristin) administered by intermittent or continuous in vitro pharmacodynamic infection model with simulated endocardial vegetations
31. Treatment of endocarditis due to vancomycin-resistant Enterococcus faecium with quinupristin/ dalfopristin, doxycycline and rifampin: A synergistic drug combination
32. Efficacy of linezolid in a staphylococcal endocarditis rabbit model
33. Linezolid therapy of vancomycin-resistant Enterococcus faecium experimental endocarditis
34. Successful treatment of vancomycin-resistant Enterococcus endocarditis with oral linezolid
35. Activity of LY333328 combined with gentamicin in vitro and in rabbit experimental endocarditis due to vancomycin-susceptible or -resistant Enterococcus faecalis
36. Bactericidal activities of two daptomycin regimens against clinical strains of glycopeptide intermediate-resistant Staphylococcus aureus, methicillin-resistant Staphylococcus aureus isolates in an in vitro pharmacodynamic model with simulated endocardial vegetations
37. In vivo activity of evernimicin (SCH 27899) against methicillin-resistant Staphylococcus aureus in experimental infective endocarditis
38. In vivo activities of evernimicin (SCH 27899) against vancomycin-susceptible and vancomycin-resistant enterococci in experimental endocarditis
39. Early or delayed surgery in acute native aortic valve endocarditis?
40. Prognosis of native valve endocarditis: A review of 253 cases
41. Devenir des abcès cardiaques paraannulaires traités médicalement: Tentative d'identification des critères de prognostic favorable
42. Valve replacement in patients with endocarditis and cerebral septic emboli
43. Dringlicher Herzklappenersatz nach Hirnembolie während florider
44. Surgical management of infective endocarditis associated with cerebral complications. Multicenter retrospective study in Japan
45. Valve replacement in patients with endocarditis and acute neurologic deficit
46. Splenic septic emboli in endocarditis
47. Conservative operation for infective endocarditis of the mitral valve
48. La chirurgie mitrale conservatrice dans le traitement de l'insuffisance mitrale infectieuse
49. Is there an advantage to repairing infected mitral valves?
50. Tricuspid valve endocarditis
51. Surgical management of aortic root abscess
52. Prosthetic valve endocarditis with ring abscesses. Surgical management and long-term results
53. Surgical treatment of active infective endocarditis with paravalvular involvement
54. Results of allograft aortic valve replacement for complex endocarditis
55. Allograft aortic root replacement in prosthetic aortic valve endocarditis: A review of 32 patients
56. Treatment of aortic valve endocarditis with the Ross operation
57. Long-term results of surgery for active infective endocarditis
58. Surgical treatment of prosthetic valve endocarditis
59. Aortic valve endocarditis. Determinants of early survival and late morbidity
60. L'espérance de vie des malades opérés pour endocardite infectieuse aortique a-t-elle augmenté dans les douze dernières années?
61. Early and late survival after surgical treatment of culture-positive active endocarditis
62. Prevention of bacterial endocarditis. Recommendations by the American Heart Association
63. Prophylaxis of infective endocarditis for dental procedures. Report of a working party of the European Society of Cardiology
64. Empfehlungen zur Prophylaxe bakterieller Endokarditiden
65. Prophylaxie de l'endocardite infectieuse. Recommandations du jury de la conférence de consensus du 27 Mars 1992
66. Antibiotic prophylaxis for infective endocarditis from an international group of experts towards a European consensus
67. Prophylaxe der bakteriellen Endokarditis
68. Recommendations for endocarditis prophylaxis
69. Antibiotic prophylaxis and infective endocarditis
70. Prophylaxie de l'endocardite infectieuse. Recommandations du jury
71. Prevention of infective endocarditis
72. Comparison of single doses of amoxicillin or of amoxicillin-gentamicin for the prevention of endocarditis caused by Streptococcus faecalis and by viridans streptococci
73. Successful single dose amoxicillin prophylaxis against experimental endocarditis: Evidence for two mechanisms of protection
74. Does prophylaxis prevent postdental infective endocarditis? A controlled evaluation of protective efficacy
75. Procedures associated with infective endocarditis in adults. A case-control study
76. Efficacy of antibiotic prophylaxis for prevention of native-valve endocarditis
77. Apparent failures of endocarditis prophylaxis. Analysis of 52 cases submitted to a national registry
78. Survey of compliance with American Heart Association guidelines for prevention of bacterial endocarditis
79. Enquête sur la pratique actuelle de l'antibioprophylaxie de l'endocardite infectieuse par les dentistes
80. Failure of provision of antibiotic prophylaxis for 'at risk' cardiac patients: Impetus for improvement required from cardiologists
81. Chemoprophylaxis for bacterial endocarditis. A survey of current practice in London
82. Antibiotic prophylaxis of subacute bacterial endocarditis for adult patients by dentists in Date Country, Florida
83. Recommendations for prevention of bacterial endocarditis: Compliance by dental general practitioners
84. Prophylaxie de l'endocardite infectieuse. Résultat d'une enquête en 1991 auprès de 300 médecins généralistes français
85. Les dentistes appliquent-ils correctement les recommandations pour la prophylaxie des endocardites bactériennes?
86. A critical appraisal of the quality of the management of infective endocarditis